Nalbuphine Hydrochloride
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00844 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 10 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | exercise-induced malignant hyperthermia | KG + DL |
| 2 | common cold | KG + DL |
| 3 | restless legs syndrome | KG + DL |
| 4 | allergic urticaria | KG + DL |
| 5 | familial periodic paralysis | KG + DL |
| 6 | hypokalemic periodic paralysis | KG + DL |
| 7 | insomnia (disease) | KG + DL |
| 8 | adrenal gland pheochromocytoma | KG + DL |
| 9 | attention deficit hyperactivity disorder, inattentive type | KG + DL |
| 10 | small intestine cancer | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.